HK1174037A1 - Composition and antiviral activity of substituted azaindoleoxoacetic piperazine derivatives - Google Patents
Composition and antiviral activity of substituted azaindoleoxoacetic piperazine derivativesInfo
- Publication number
- HK1174037A1 HK1174037A1 HK13101431.0A HK13101431A HK1174037A1 HK 1174037 A1 HK1174037 A1 HK 1174037A1 HK 13101431 A HK13101431 A HK 13101431A HK 1174037 A1 HK1174037 A1 HK 1174037A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- composition
- antiviral activity
- piperazine derivatives
- azaindoleoxoacetic piperazine
- substituted azaindoleoxoacetic
- Prior art date
Links
- 230000000840 anti-viral effect Effects 0.000 title 1
- 150000004885 piperazines Chemical class 0.000 title 1
- 229940066771 systemic antihistamines piperazine derivative Drugs 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/427—Thiazoles not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4402—Non condensed pyridines; Hydrogenated derivatives thereof only substituted in position 2, e.g. pheniramine, bisacodyl
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/472—Non-condensed isoquinolines, e.g. papaverine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/472—Non-condensed isoquinolines, e.g. papaverine
- A61K31/4725—Non-condensed isoquinolines, e.g. papaverine containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/513—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim having oxo groups directly attached to the heterocyclic ring, e.g. cytosine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
- A61K31/52—Purines, e.g. adenine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/536—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines ortho- or peri-condensed with carbocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/63—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide
- A61K31/635—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide having a heterocyclic ring, e.g. sulfadiazine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
- A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
- A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
- A61K31/7068—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
- A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
- A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
- A61K31/7068—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid
- A61K31/7072—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid having two oxo groups directly attached to the pyrimidine ring, e.g. uridine, uridylic acid, thymidine, zidovudine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
- A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
- A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
- A61K31/7076—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines containing purines, e.g. adenosine, adenylic acid
- A61K31/708—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines containing purines, e.g. adenosine, adenylic acid having oxo groups directly attached to the purine ring system, e.g. guanosine, guanylic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Molecular Biology (AREA)
- General Chemical & Material Sciences (AREA)
- Communicable Diseases (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Virology (AREA)
- Oncology (AREA)
- AIDS & HIV (AREA)
- Tropical Medicine & Parasitology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US10/214,982 US20030207910A1 (en) | 2001-02-02 | 2002-08-07 | Composition and antiviral activity of substituted azaindoleoxoacetic piperazine derivatives |
Publications (1)
Publication Number | Publication Date |
---|---|
HK1174037A1 true HK1174037A1 (en) | 2013-05-31 |
Family
ID=31714265
Family Applications (4)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK05106424.8A HK1072731A1 (en) | 2002-08-07 | 2005-07-27 | Composition and antiviral activity of substituted azaindoleoxoacetic piperazine derivatives |
HK13101431.0A HK1174037A1 (en) | 2002-08-07 | 2005-07-27 | Composition and antiviral activity of substituted azaindoleoxoacetic piperazine derivatives |
HK15102916.0A HK1202530A1 (en) | 2002-08-07 | 2015-03-23 | Composition and antiviral activity of substituted azaindoleoxoacetic piperazine derivatives |
HK16108137.9A HK1220181A1 (zh) | 2002-08-07 | 2016-07-12 | 取代的氮雜吲哚氧代乙酸哌嗪衍生物的組合物及抗病毒作用 |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK05106424.8A HK1072731A1 (en) | 2002-08-07 | 2005-07-27 | Composition and antiviral activity of substituted azaindoleoxoacetic piperazine derivatives |
Family Applications After (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK15102916.0A HK1202530A1 (en) | 2002-08-07 | 2015-03-23 | Composition and antiviral activity of substituted azaindoleoxoacetic piperazine derivatives |
HK16108137.9A HK1220181A1 (zh) | 2002-08-07 | 2016-07-12 | 取代的氮雜吲哚氧代乙酸哌嗪衍生物的組合物及抗病毒作用 |
Country Status (31)
Country | Link |
---|---|
US (1) | US20030207910A1 (fr) |
EP (4) | EP1549313B9 (fr) |
KR (1) | KR101045154B1 (fr) |
CN (2) | CN101229164B (fr) |
AR (1) | AR041190A1 (fr) |
AU (2) | AU2003261367B2 (fr) |
BR (1) | BRPI0313286B8 (fr) |
CA (1) | CA2494832C (fr) |
CY (3) | CY1113413T1 (fr) |
DK (3) | DK2801576T3 (fr) |
ES (4) | ES2560844T3 (fr) |
GE (1) | GEP20084284B (fr) |
HK (4) | HK1072731A1 (fr) |
HR (1) | HRP20050123B8 (fr) |
HU (1) | HUE027396T2 (fr) |
IL (1) | IL166512A (fr) |
IS (1) | IS2919B (fr) |
MX (1) | MXPA05001441A (fr) |
MY (1) | MY146549A (fr) |
NO (1) | NO331591B1 (fr) |
NZ (1) | NZ537930A (fr) |
PE (1) | PE20040772A1 (fr) |
PL (1) | PL219566B1 (fr) |
PT (3) | PT1549313E (fr) |
RS (1) | RS53428B (fr) |
RU (1) | RU2325389C2 (fr) |
SI (3) | SI2497770T1 (fr) |
TW (1) | TWI328452B (fr) |
UA (1) | UA82199C2 (fr) |
WO (1) | WO2004014380A1 (fr) |
ZA (1) | ZA200501018B (fr) |
Families Citing this family (25)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB0307834D0 (en) * | 2003-04-04 | 2003-05-14 | Ta Contrast Ab | Composition |
US20050075364A1 (en) * | 2003-07-01 | 2005-04-07 | Kap-Sun Yeung | Indole, azaindole and related heterocyclic N-substituted piperazine derivatives |
US20050124623A1 (en) * | 2003-11-26 | 2005-06-09 | Bender John A. | Diazaindole-dicarbonyl-piperazinyl antiviral agents |
US7745625B2 (en) | 2004-03-15 | 2010-06-29 | Bristol-Myers Squibb Company | Prodrugs of piperazine and substituted piperidine antiviral agents |
US7776863B2 (en) * | 2004-03-24 | 2010-08-17 | Bristol-Myers Squibb Company | Methods of treating HIV infection |
US20050215544A1 (en) * | 2004-03-24 | 2005-09-29 | Pin-Fang Lin | Methods of treating HIV infection |
JP2008501758A (ja) | 2004-06-09 | 2008-01-24 | グラクソ グループ リミテッド | ピロロピリジン誘導体 |
US20060100209A1 (en) * | 2004-11-09 | 2006-05-11 | Chong-Hui Gu | Formulations of 1-(4-benzoyl-piperazin-1-yl)-2-[4-methoxy-7-(3-methyl-[1,2,4]triazol-1-yl)-1H-pyrrolo[2,3-c]pyridin-3-yl]-ethane-1,2-dione |
US20060100432A1 (en) * | 2004-11-09 | 2006-05-11 | Matiskella John D | Crystalline materials of 1-(4-benzoyl-piperazin-1-yl)-2-[4-methoxy-7-(3-methyl-[1,2,4]triazol-1-yl)-1H-pyrrolo[2,3-c]pyridin-3-yl]-ethane-1,2-dione |
US7183284B2 (en) * | 2004-12-29 | 2007-02-27 | Bristol-Myers Squibb Company | Aminium salts of 1,2,3-triazoles as prodrugs of drugs including antiviral agents |
US7601715B2 (en) | 2005-06-22 | 2009-10-13 | Bristol-Myers Squibb Company | Process for preparing triazole substituted azaindoleoxoacetic piperazine derivatives and novel salt forms produced therein |
US7598380B2 (en) * | 2005-08-03 | 2009-10-06 | Bristol-Myers Squibb Company | Method of preparation of azaindole derivatives |
US7851476B2 (en) * | 2005-12-14 | 2010-12-14 | Bristol-Myers Squibb Company | Crystalline forms of 1-benzoyl-4-[2-[4-methoxy-7-(3-methyl-1H-1,2,4-triazol-1-YL)-1-[(phosphonooxy)methyl]-1H-pyrrolo[2,3-C]pyridin-3-YL]-1,2-dioxoethyl]-piperazine |
US7807671B2 (en) * | 2006-04-25 | 2010-10-05 | Bristol-Myers Squibb Company | Diketo-piperazine and piperidine derivatives as antiviral agents |
US7504399B2 (en) * | 2006-06-08 | 2009-03-17 | Bristol-Meyers Squibb Company | Piperazine enamines as antiviral agents |
US8318941B2 (en) * | 2006-07-06 | 2012-11-27 | Bristol-Myers Squibb Company | Pyridone/hydroxypyridine 11-beta hydroxysteroid dehydrogenase type I inhibitors |
JP5731978B2 (ja) | 2008-09-26 | 2015-06-10 | インテリカイン, エルエルシー | 複素環キナーゼ阻害剤 |
GB0910667D0 (en) * | 2009-06-19 | 2009-08-05 | Glaxo Wellcome Mfg Pte Ltd | Novel compounds |
WO2012019003A1 (fr) * | 2010-08-06 | 2012-02-09 | Bristol-Myers Squibb Company | Dérivés d'oxoacétyl pipérazinamide à substitution indole et azaindole |
WO2012075235A1 (fr) * | 2010-12-02 | 2012-06-07 | Bristol-Myers Squibb Company | Amides d'alkyle comme inhibiteurs d'attachement du vih |
CN102718692B (zh) * | 2012-07-03 | 2014-01-08 | 苏州和健医药科技有限公司 | 一种7位甲基-5位氧取代吲哚化合物的制备方法 |
US9580416B2 (en) | 2014-07-02 | 2017-02-28 | Pharmacyclics Llc | Inhibitors of Bruton's tyrosine kinase |
EA201790604A1 (ru) * | 2014-09-17 | 2017-09-29 | Селджен Квонтисел Рисёрч, Инк. | Ингибиторы гистондеметилазы |
CN107847495A (zh) | 2015-05-06 | 2018-03-27 | 加利福尼亚大学董事会 | K‑Ras调节剂 |
EP4340839A1 (fr) * | 2021-05-21 | 2024-03-27 | Centre National de la Recherche Scientifique (CNRS) | Nouveaux derives azaindole en tant qu'agents antiviraux |
Family Cites Families (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2761201A (en) | 1952-05-02 | 1956-09-04 | Griffin Wheel Co | Renewing molds |
US3830602A (en) | 1973-03-14 | 1974-08-20 | Commercial Shearing | Rotary pumps and motors |
US5023265A (en) * | 1990-06-01 | 1991-06-11 | Schering Corporation | Substituted 1-H-pyrrolopyridine-3-carboxamides |
IL99843A0 (en) | 1990-11-01 | 1992-08-18 | Merck & Co Inc | Synergistic combination of hiv reverse transcriptase inhibitors |
US5811432A (en) | 1990-11-09 | 1998-09-22 | Pfizer Inc | Azaoxindole derivatives |
ES2097341T3 (es) | 1991-07-03 | 1997-04-01 | Upjohn Co | Indoles sustituidos como farmacos para el tratamiento del sida. |
WO1993005020A1 (fr) | 1991-09-06 | 1993-03-18 | Merck & Co., Inc. | Indoles utilises comme inhibiteurs de la transcriptase inverse du vih |
US5124327A (en) * | 1991-09-06 | 1992-06-23 | Merck & Co., Inc. | HIV reverse transcriptase |
US5413999A (en) | 1991-11-08 | 1995-05-09 | Merck & Co., Inc. | HIV protease inhibitors useful for the treatment of AIDS |
IT1265057B1 (it) | 1993-08-05 | 1996-10-28 | Dompe Spa | Tropil 7-azaindolil-3-carbossiamidi |
US5424329A (en) * | 1993-08-18 | 1995-06-13 | Warner-Lambert Company | Indole-2-carboxamides as inhibitors of cell adhesion |
GB9420521D0 (en) | 1994-10-12 | 1994-11-30 | Smithkline Beecham Plc | Novel compounds |
JP2003500403A (ja) | 1999-05-21 | 2003-01-07 | サイオス,インコーポレーテッド | p38キナーゼのインヒビターとしてのインドール型誘導体 |
US6469006B1 (en) | 1999-06-15 | 2002-10-22 | Bristol-Myers Squibb Company | Antiviral indoleoxoacetyl piperazine derivatives |
US6476034B2 (en) | 2000-02-22 | 2002-11-05 | Bristol-Myers Squibb Company | Antiviral azaindole derivatives |
US20020061892A1 (en) * | 2000-02-22 | 2002-05-23 | Tao Wang | Antiviral azaindole derivatives |
CA2413044A1 (fr) | 2000-07-10 | 2002-01-17 | Bristol-Myers Squibb Company | Composition et activite antivirale de derives de piperazine indoleoxoacetique substitues |
US6403211B1 (en) | 2000-07-18 | 2002-06-11 | 3M Innovative Properties Company | Liquid crystal polymer for flexible circuits |
PT1363705E (pt) * | 2001-02-02 | 2012-08-17 | Bristol Myers Squibb Co | Composição e actividade antiviral de derivados de piperazina azaindoleoxoacética substituídos |
EP1476163A4 (fr) * | 2002-02-23 | 2009-05-27 | Bristol Myers Squibb Co | Procede de traitement de l'infection par le vih consistant a eviter toute interaction du cd4 et du gp120 |
-
2002
- 2002-08-07 US US10/214,982 patent/US20030207910A1/en not_active Abandoned
-
2003
- 2003-05-08 UA UAA200502051A patent/UA82199C2/uk unknown
- 2003-08-04 MX MXPA05001441A patent/MXPA05001441A/es active IP Right Grant
- 2003-08-04 RU RU2005106350/04A patent/RU2325389C2/ru active
- 2003-08-04 RS YU20050108A patent/RS53428B/en unknown
- 2003-08-04 NZ NZ537930A patent/NZ537930A/en not_active IP Right Cessation
- 2003-08-04 CN CN2008100099420A patent/CN101229164B/zh not_active Expired - Lifetime
- 2003-08-04 CN CNB038237431A patent/CN100379421C/zh not_active Expired - Lifetime
- 2003-08-05 PT PT03784906T patent/PT1549313E/pt unknown
- 2003-08-05 AU AU2003261367A patent/AU2003261367B2/en not_active Ceased
- 2003-08-05 GE GEAP20038674A patent/GEP20084284B/en unknown
- 2003-08-05 ES ES14164659.6T patent/ES2560844T3/es not_active Expired - Lifetime
- 2003-08-05 KR KR1020057002158A patent/KR101045154B1/ko active IP Right Grant
- 2003-08-05 TW TW092121422A patent/TWI328452B/zh not_active IP Right Cessation
- 2003-08-05 PT PT121706394T patent/PT2497770E/pt unknown
- 2003-08-05 EP EP03784906A patent/EP1549313B9/fr not_active Expired - Lifetime
- 2003-08-05 EP EP15180409.3A patent/EP2975038B1/fr not_active Expired - Lifetime
- 2003-08-05 WO PCT/US2003/024415 patent/WO2004014380A1/fr active Search and Examination
- 2003-08-05 EP EP14164659.6A patent/EP2801576B1/fr not_active Expired - Lifetime
- 2003-08-05 HU HUE14164659A patent/HUE027396T2/en unknown
- 2003-08-05 PL PL375360A patent/PL219566B1/pl unknown
- 2003-08-05 ES ES15180409.3T patent/ES2641893T3/es not_active Expired - Lifetime
- 2003-08-05 ES ES03784906T patent/ES2388919T3/es not_active Expired - Lifetime
- 2003-08-05 CA CA2494832A patent/CA2494832C/fr not_active Expired - Lifetime
- 2003-08-05 DK DK14164659.6T patent/DK2801576T3/en active
- 2003-08-05 EP EP12170639.4A patent/EP2497770B1/fr not_active Expired - Lifetime
- 2003-08-05 SI SI200332361T patent/SI2497770T1/sl unknown
- 2003-08-05 BR BRPI0313286A patent/BRPI0313286B8/pt not_active IP Right Cessation
- 2003-08-05 DK DK12170639.4T patent/DK2497770T3/da active
- 2003-08-05 PT PT141646596T patent/PT2801576E/pt unknown
- 2003-08-05 SI SI200332464T patent/SI2801576T1/sl unknown
- 2003-08-05 SI SI200332192T patent/SI1549313T1/sl unknown
- 2003-08-05 ES ES12170639.4T patent/ES2481044T3/es not_active Expired - Lifetime
- 2003-08-05 DK DK03784906.4T patent/DK1549313T3/da active
- 2003-08-07 MY MYPI20033007A patent/MY146549A/en unknown
- 2003-08-07 AR ARP030102835A patent/AR041190A1/es active IP Right Grant
- 2003-08-07 PE PE2003000789A patent/PE20040772A1/es active IP Right Grant
-
2005
- 2005-01-26 IL IL166512A patent/IL166512A/en active IP Right Grant
- 2005-01-28 NO NO20050514A patent/NO331591B1/no not_active IP Right Cessation
- 2005-02-01 IS IS7682A patent/IS2919B/is unknown
- 2005-02-03 ZA ZA200501018A patent/ZA200501018B/en unknown
- 2005-02-07 HR HRP20050123AA patent/HRP20050123B8/hr not_active IP Right Cessation
- 2005-07-27 HK HK05106424.8A patent/HK1072731A1/xx not_active IP Right Cessation
- 2005-07-27 HK HK13101431.0A patent/HK1174037A1/xx not_active IP Right Cessation
-
2009
- 2009-06-12 AU AU2009202361A patent/AU2009202361B2/en not_active Ceased
-
2012
- 2012-08-21 CY CY20121100745T patent/CY1113413T1/el unknown
-
2014
- 2014-07-31 CY CY20141100578T patent/CY1115580T1/el unknown
-
2015
- 2015-03-23 HK HK15102916.0A patent/HK1202530A1/xx not_active IP Right Cessation
-
2016
- 2016-02-26 CY CY20161100162T patent/CY1117217T1/el unknown
- 2016-07-12 HK HK16108137.9A patent/HK1220181A1/zh unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1220181A1 (zh) | 取代的氮雜吲哚氧代乙酸哌嗪衍生物的組合物及抗病毒作用 | |
TWI318978B (en) | Composition and antiviral activity of substituted azaindoleoxoacetic piperazine derivatives | |
PL376566A1 (pl) | Pochodne podstawionych 2-alkiloamino-nikotynamidów oraz sposoby wykorzystania | |
EP1465615A4 (fr) | Derives de bis- enone tricyclique et methodes d'utilisation | |
PL1648874T3 (pl) | Pochodne piperazyny i ich zastosowanie jako środków leczniczych | |
SI1583763T1 (sl) | Benzoazolilpiperazinski derivati, ki imajo VR1 antagonistično delovanje | |
PL376532A1 (pl) | Pochodne podstawionych benzyloamin oraz sposoby wykorzystania | |
HK1061854A1 (en) | Spirotricyclic derivatives and their use as phosphodiesterase-7 inhibitors | |
HK1099014A1 (en) | Malonamide derivatives blocking the activity of gama-secretase | |
PL376575A1 (pl) | Podstawione związki heterocykliczne oraz sposoby wykorzystania | |
HUP0401735A3 (en) | Piperazine derivatives with ccr1 receptor antagonist activity and pharmaceutical compositions containing them | |
HK1080487A1 (en) | Heterocyclic compounds having elastase-inhibiting activity and intermediates thereof | |
HUP0303364A3 (en) | Pyrimidine derivatives of arylalkane-sulfonamides having endothelin-antagonist activity, pharmaceutical compositions containing them and their use | |
IL164836A0 (en) | Phosphonates and derivatives thereof as enhancers of the activity of insecticides | |
PL378027A1 (pl) | Nowe pochodne piperazyny i ich zastosowanie jako związków pośrednich w syntezie | |
SI1363705T1 (sl) | Sestavek in antivirusna aktivnost substituiranih azaindoleoksoocetnih piperazinskih derivatov | |
EP1559719A4 (fr) | Nouveaux derives de macrolides potentialisant une activite antifongique | |
AU2003264474A8 (en) | Novel uracil derivatives and medicinal use thereof | |
HK1073243A1 (en) | Use of N-(indolecarbonyl-) piperazine derivatives | |
AU2003260515A8 (en) | Derivatives of 4-4'-bipyridyl-2-2'-bisoxazoles and 4-4'-bipyridyl-2-2'-bistiazoles as antineoplasic agents | |
HUP0203929D0 (en) | New use of substituted alkyl-piridazinone derivatives | |
TH103167B (th) | สารผสมและแอคติวิตีต้านไวรัสของอนุพันธ์อะซาอินโดลออกโซอะซีติกพิเพอราซีนซึ่งถูกแทนที่ | |
ZA200500735B (en) | Novel quinuclidine derivatives and their use | |
PL360228A1 (en) | Application of carborates and metalcarborates and their derivatives |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PC | Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee) |
Effective date: 20210811 |